Berres Jennifer 4
Research Summary
AI-generated summary
HCA SVP Jennifer Berres Receives 6,206 Stock Appreciation Rights
What Happened Jennifer Berres, Senior Vice President and Chief Human Resources Officer of HCA Healthcare, was granted 6,206 stock appreciation rights (SARs) on January 29, 2026. The award is reported as a derivative grant with an acquisition price shown as $0.00 — this is a compensation award, not a market purchase or sale.
Key Details
- Transaction date: January 29, 2026; Form 4 filed February 2, 2026 (filing appears timely).
- Transaction type/code: Award/Grant (A); 6,206 SARs granted; price listed $0.00.
- Vesting: SARs vest in four equal annual installments beginning January 29, 2027 (per footnote).
- Shares owned after transaction: Not specified in the filing.
- No indication of a 10b5-1 plan, tax-withholding sale, or late filing in this report.
Context
- Stock appreciation rights are derivative compensation awards that typically allow the holder to receive the appreciation in HCA stock value (in cash or shares) upon exercise; they are not the same as an immediate stock purchase.
- Because this is a compensation grant, it should be viewed as part of executive pay rather than a direct insider buy or sell signal.